Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian D Davis

Showing results (71-80 of 281) with videos related to

Pageof 29
Sort By:
Asia-Pacific Journal of Clinical Oncology|October 25, 2013
Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic groupAli Tafreshi, Eddy Thientosapol, Mun Sem Liew, et al.
European Urology|May 21, 2026
Reply to Daoyuan Li's Words of Wisdom re: Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette Guérin-naïve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.011Dickon Hayne, Alison Y Zhang, Hayley Thomas, et al.
European Urology Focus|May 27, 2026
Reply to Tonghu Liu's Letter to the Editor re: Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette Guérin-naïve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.009Dickon Hayne, Alison Y Zhang, Hayley Thomas, et al.
BJU International|April 10, 2017
BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learnedDickon Hayne, Martin Stockler, Steve P McCombie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Tumor antigen expression in melanoma varies according to antigen and stageCatherine Barrow, Judy Browning, Duncan MacGregor, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|June 23, 2006
Xenografting tumour beneath the renal capsule using modern surgical equipmentNathan Lawrentschuk, Angela Rigopoulos, Fook-Thean Lee, et al.
Melanoma Research|January 28, 2014
A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programmeDavid K Lau, Miles C Andrews, Natalie Turner, et al.
BMJ Supportive & Palliative Care|August 10, 2021
Advanced prostate cancer experimental radioactive treatment-clinical trial decision making: patient experiencesBianca Viljoen, Michael S Hofman, Suzanne K Chambers, et al.
The Lancet. Healthy Longevity|May 12, 2023
Integrated care for older people with cancer: a primary care focusWee Kheng Soo, Vicky Yin, Jane Crowe, et al.
Psycho-Oncology|July 15, 2025
How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative PerspectiveNatasha A Roberts, Ian D Davis, David Wyld, et al.
Pageof 29

Showing results (71-80 of 281) with videos related to

Sort By:
Pageof 29
Asia-Pacific Journal of Clinical Oncology|October 25, 2013
Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic groupAli Tafreshi, Eddy Thientosapol, Mun Sem Liew, et al.
European Urology|May 21, 2026
Reply to Daoyuan Li's Words of Wisdom re: Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette Guérin-naïve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.011Dickon Hayne, Alison Y Zhang, Hayley Thomas, et al.
European Urology Focus|May 27, 2026
Reply to Tonghu Liu's Letter to the Editor re: Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette Guérin-naïve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.009Dickon Hayne, Alison Y Zhang, Hayley Thomas, et al.
BJU International|April 10, 2017
BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learnedDickon Hayne, Martin Stockler, Steve P McCombie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Tumor antigen expression in melanoma varies according to antigen and stageCatherine Barrow, Judy Browning, Duncan MacGregor, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|June 23, 2006
Xenografting tumour beneath the renal capsule using modern surgical equipmentNathan Lawrentschuk, Angela Rigopoulos, Fook-Thean Lee, et al.
Melanoma Research|January 28, 2014
A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programmeDavid K Lau, Miles C Andrews, Natalie Turner, et al.
BMJ Supportive & Palliative Care|August 10, 2021
Advanced prostate cancer experimental radioactive treatment-clinical trial decision making: patient experiencesBianca Viljoen, Michael S Hofman, Suzanne K Chambers, et al.
The Lancet. Healthy Longevity|May 12, 2023
Integrated care for older people with cancer: a primary care focusWee Kheng Soo, Vicky Yin, Jane Crowe, et al.
Psycho-Oncology|July 15, 2025
How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative PerspectiveNatasha A Roberts, Ian D Davis, David Wyld, et al.
Pageof 29